Optical Spectroscopy to Guide Photodynamic Therapy of Head and Neck Tumors

In contrast to other interstitial applications of photodynamic therapy (PDT), optical guidance or monitoring in the head and neck is at a very early stage of development. The present paper reviews the use of optical approaches, in particular optical spectroscopy, that have been used or have the potential to guide the application of PDT. When considering the usefulness of these methods, it is important to consider the volume over which these measurements are acquired, the influence of differences in and changes to the background optical properties, the implications for these effects on the measured parameters and the difficulty of incorporating these types of measurements in clinical practice in head and neck PDT. To illustrate these considerations, we present an application of a recently developed technique, which we term fluorescence differential path length spectroscopy for monitoring meta-tetra(hydroxyphenyl)-chlorin or Foscan-PDT of interstitial head and neck cancer.

[1]  Thomas H. Foster,et al.  In Vivo mTHPC Photobleaching in Normal Rat Skin Exhibits Unique Irradiance-dependent Features¶ , 2002, Photochemistry and photobiology.

[2]  L. Kunz,et al.  Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver , 2004, British Journal of Cancer.

[3]  T. Hasan,et al.  PHOTOPHYSICAL AND PHOTOSENSITIZING PROPERTIES OF BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD‐MA) * , 1994, Photochemistry and photobiology.

[4]  E. Hull,et al.  Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin In Vivo¶ , 2001, Photochemistry and photobiology.

[5]  Jarod C Finlay,et al.  Interstitial Fluorescence Spectroscopy in the Human Prostate During Motexafin Lutetium–Mediated Photodynamic Therapy , 2006, Photochemistry and photobiology.

[6]  W. Jerjes,et al.  The application of photodynamic therapy in the head and neck. , 2007, Dental update.

[7]  Ken Kang-Hsin Wang,et al.  A comprehensive mathematical model of microscopic dose deposition in photodynamic therapy. , 2006, Medical physics.

[8]  B. Krammer,et al.  Vascular effects of photodynamic therapy. , 2001, Anticancer research.

[9]  Jarod C Finlay,et al.  Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy. , 2005, Photochemistry and photobiology.

[10]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[11]  Stefan Andersson-Engels,et al.  Towards accurate in vivo spectroscopy of the human prostate , 2008, Journal of biophotonics.

[12]  K. Lorenz,et al.  Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan®) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients , 2009, European Archives of Oto-Rhino-Laryngology.

[13]  Henricus J C M Sterenborg,et al.  The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus. , 2006, Gastrointestinal endoscopy.

[14]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[15]  C. Hadjur,et al.  Pharmacokinetics of Tetra (m‐hydroxyphenyl)chlorin in Human Plasma and Individualized Light Dosimetry in Photodynamic Therapy , 1998, Photochemistry and photobiology.

[16]  Lise Lyngsnes Randeberg,et al.  Monitoring of hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladder cancer by optical spectroscopy. , 2008, Journal of biomedical optics.

[17]  B. Kruijt,et al.  Laser speckle imaging of dynamic changes in flow during photodynamic therapy , 2006, Lasers in Medical Science.

[18]  C. Hadjur,et al.  Spectroscopic studies of photobleaching and photoproduct formation of meta(tetrahydroxyphenyl)chlorin (m-THPC) used in photodynamic therapy. The production of singlet oxygen by m-THPC , 1998 .

[19]  Timothy C. Zhu,et al.  Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium–mediated Photodynamic Therapy¶ , 2005 .

[20]  Theresa M Busch,et al.  Fluence rate as a modulator of PDT mechanisms , 2006, Lasers in surgery and medicine.

[21]  Brian W. Pogue,et al.  Estimation of Oxygen Distribution in RIF-1 Tumors by Diffusion Model-Based Interpretation of Pimonidazole Hypoxia and Eppendorf Measurements , 2001, Radiation research.

[22]  Victor X D Yang,et al.  A multispectral fluorescence imaging system: Design and initial clinical tests in intra‐operative Photofrin‐photodynamic therapy of brain tumors , 2003, Lasers in surgery and medicine.

[23]  Zheng Huang,et al.  Combination of Photodynamic Therapy and Immunomodulation: Current Status and Future Trends , 2008 .

[24]  Adrian Mariampillai,et al.  Intravital high-resolution optical imaging of individual vessel response to photodynamic treatment. , 2008, Journal of biomedical optics.

[25]  T. Mang,et al.  Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. , 1985, Cancer research.

[26]  Arjen Amelink,et al.  Measurement of the local optical properties of turbid media by differential path-length spectroscopy. , 2004, Applied optics.

[27]  Quantitative fluorescence spectroscopy in turbid media using fluorescence differential path length spectroscopy. , 2008, Journal of biomedical optics.

[28]  Thomas Pongratz,et al.  ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[29]  Jarod C Finlay,et al.  Real-time In Situ Monitoring of Human Prostate Photodynamic Therapy with Diffuse Light , 2006, Photochemistry and photobiology.

[30]  W. Star,et al.  Light dosimetry in vivo. , 1997, Physics in medicine and biology.

[31]  G. Puppels,et al.  Towards oncological application of Raman spectroscopy , 2009, Journal of biophotonics.

[32]  Michael S Patterson,et al.  Relationship Between mTHPC Fluorescence Photobleaching and Cell Viability During In Vitro Photodynamic Treatment of DP16 Cells¶ , 2002, Photochemistry and photobiology.

[33]  A. Amelink,et al.  Monitoring PDT by means of superficial reflectance spectroscopy. , 2005, Journal of photochemistry and photobiology. B, Biology.

[34]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.

[35]  P. Lambin,et al.  Oxygenation of head and neck tumors , 1993, Cancer.

[36]  B. Wilson,et al.  Spectroscopy and fluorescence in esophageal diseases. , 2006, Best practice & research. Clinical gastroenterology.

[37]  L. Kunz,et al.  Intracellular Photobleaching of 5,10,15,20-Tetrakis(m-hydroxyphenyl) chlorin (Foscan®) Exhibits a Complex Dependence on Oxygen Level and Fluence Rate¶ , 2002, Photochemistry and photobiology.

[38]  A. Curnow,et al.  Optimisation of Illumination for Photodynamic Therapy With mTHPC on Normal Colon and a Transplantable Tumour in Rats , 2002, Lasers in Medical Science.

[39]  B. Wilson,et al.  The physics, biophysics and technology of photodynamic therapy , 2008, Physics in medicine and biology.

[40]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.

[41]  Shoko Nioka,et al.  Noninvasive diffuse optical measurement of blood flow and blood oxygenation for monitoring radiation therapy in patients with head and neck tumors: a pilot study. , 2006, Journal of biomedical optics.

[42]  Arjen Amelink,et al.  Monitoring ALA‐induced PpIX Photodynamic Therapy in the Rat Esophagus Using Fluorescence and Reflectance Spectroscopy , 2008, Photochemistry and photobiology.

[43]  M. Korbelik,et al.  Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.

[44]  Brian W Pogue,et al.  Analysis of sampling volume and tissue heterogeneity on the in vivo detection of fluorescence. , 2005, Journal of biomedical optics.

[45]  Thomas H Foster,et al.  Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas , 2008, Clinical Cancer Research.

[46]  Kai Zhang,et al.  Techniques for delivery and monitoring of TOOKAD(WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities , 2005, SPIE BiOS.

[47]  T. Foster,et al.  Effects of Fluence Rate on Cell Survival and Photobleaching in Meta-Tetra-(hydroxyphenyl)chlorin–photosensitized Colo 26 Multicell Tumor Spheroids¶ , 2001, Photochemistry and photobiology.

[48]  B. Henderson,et al.  BIODISTRIBUTION AND PDT EFFICACY OF A KETOCHLORIN PHOTOSENSITIZER AS A FUNCTION OF THE DELIVERY VEHICLE , 1994, Photochemistry and photobiology.

[49]  Wiley Interscience,et al.  Performance of a dedicated light delivery and dosimetry device for photodynamic therapy of nasopharyngeal carcinoma: Phantom and volunteer experiments , 2007, Lasers in surgery and medicine.

[50]  Michael J. Emanuele,et al.  Treatment-Induced Changes in Tumor Oxygenation Predict Photodynamic Therapy Outcome , 2004, Cancer Research.

[51]  I J Bigio,et al.  Non-invasive measurement of chemotherapy drug concentrations in tissue: preliminary demonstrations of in vivo measurements. , 1999, Physics in medicine and biology.

[52]  I. Tan,et al.  mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma , 2004, International journal of cancer.